{"id":"W2055491409","doi":"10.3389/fonc.2014.00329","title":"Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC","year":2014,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer research; Epidermal growth factor receptor; Anaplastic lymphoma kinase; Crizotinib; Targeted therapy; Medicine; PTEN; Adenocarcinoma; Wnt signaling pathway; Lung cancer; Receptor tyrosine kinase; Trk receptor; Tyrosine kinase; PI3K/AKT/mTOR pathway; Protein kinase B; Epithelial–mesenchymal transition; Erlotinib; Signal transduction; Cancer; Oncology; Biology; Metastasis; Internal medicine; Receptor; Neurotrophin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004680828,0.0003400225,0.006419929,0.0005443082,0.00003120408,0.000013073,0.0001011294,0.00037756,0.00002126738],"category_scores_gemma":[0.002692835,0.0002415297,0.0004468628,0.0002414926,0.000143934,0.00003642822,0.00005100441,0.0007691379,0.00001187113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009461053,"about_ca_system_score_gemma":0.001829673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002693866,"about_ca_topic_score_gemma":0.00004050176,"domain_scores_codex":[0.9944681,0.002213268,0.002282552,0.0005595689,0.0001294852,0.0003470521],"domain_scores_gemma":[0.997217,0.001482562,0.0008198502,0.0002675114,0.00003606627,0.0001770219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007907997,0.0004823171,0.001205067,0.005697405,0.0003310782,0.0001400938,0.0001660858,3.665332e-7,1.442403e-8,0.00001407918,0.01009671,0.9817877],"study_design_scores_gemma":[0.005296702,0.0006926399,0.0002181172,0.005960194,0.003990926,0.0000518517,0.00005479941,0.0000660783,3.434779e-8,0.0001698542,0.9833126,0.0001861848],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002175154,0.9891597,0.001957639,0.000173284,0.004222698,0.003361428,0.00002749356,0.00001467103,0.001061306],"genre_scores_gemma":[0.00005217925,0.9868882,0.0115704,0.0001025755,0.0003781647,0.0005656046,0.0001883733,0.00004276087,0.0002117155],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9816015,"threshold_uncertainty_score":0.9849297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1576575008798927,"score_gpt":0.5599445184976513,"score_spread":0.4022870176177585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}